Clinical Trials Browser

Phase 2 × Adamantinoma × Clear all

NCT02367859 2024-01-30

Dabrafenib and Trametinib in Treating Patients With BRAF Mutated Ameloblastoma

Phase 2 Completed

1 enrolled 5 charts

Ameloblastoma, Adamantinoma